Zadnji put ažurirano :
19/11/2024
vitamini   Ascorbic acid  
injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti način davanja lijeka Bibliografija pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Acido ascorbico Čile, Ekvador, Kolumbija, Venecuela
Acmel Turska
Adeene vitamina C Argentina
Amsac Meksiko
Ascorbic acid Australija, novi Zeland, Ujedinjeni Arapski Emirati, Velika Britanija
Ascorbil Peru
Ascorbinezuur Nizozemska
Ascorell Njemačka
Ascorvit Njemačka
Bio C Peru
C Viton Egipat
Cebion Njemačka
Cemin Ekvador
Cevalin Meksiko
Cevarol Egipat
Cevitol Austrija
Infalet Meksiko
Laperox Meksiko
Laroscorbine Francuska, Maroko
Mega C acid Kanada
Mel C Austrija
Osve vitamin C Iran
Pascorbin Ekvador
Synum Njemačka
Viciforte Italija
Vitamedic Rumunjska
Vitamin C Austrija, Iran, Kanada, Madžarska, Njemačka
Vitamina C Argentina, Italija, Kolumbija, Rumunjska, Venecuela
Vitamine C Švicarska
Vitaminum C Poljska
Bibliografija   injekcija   Bibliografija : Ascorbic acid  
Vrsta Publikacija
319 Časopis Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
552 Časopis Martinez JF, Trissel LA, Gilbert DL.
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Int J Pharm Compound 1997 ; 1: 356-358.
939 Časopis Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1057 Časopis Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1995 Časopis Chin A, Liu S, Ting-Chan J, Gill MA.
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Am J Health-Syst Pharm 2005 ; 62: 1073-1074.
3128 Laboratorija Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3549 Laboratorija Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3588 Laboratorija Vancomycine (Vancocin®) - Résumé des caractéristiques du produit
Sandoz 2011
3646 Laboratorija Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2013
3674 Laboratorija Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3932 Laboratorija Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
4154 Laboratorija Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4245 Plakat Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE.
Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
2019
4471 Laboratorija Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4510 Časopis Stawny M, Gostyńska A, Olijarczyk R, Dettlaff K, Jelińska A, Ogrodowczyk M.
Stability studies of parenteral nutrition with a high dose of vitamin C.
J Oncol Pharm Practice 2020 ;26,8:1894–1902

  Mentions Légales